Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Dispenzieri

Showing results (321-330 of 759) with videos related to

Pageof 76
Sort By:
The American Journal of Cardiology|March 25, 2008
Evidence of impaired left ventricular systolic function by Doppler myocardial imaging in patients with systemic amyloidosis and no evidence of cardiac involvement by standard two-dimensional and Doppler echocardiographyDiego Bellavia, Patricia A Pellikka, Theodore P Abraham, et al.
Blood|December 8, 2011
High-dose melphalan and peripheral blood stem cell transplantation for light-chain amyloidosis with cardiac involvementSumit Madan, Shaji K Kumar, Angela Dispenzieri, et al.
Journal of Proteome Research|August 20, 2014
Phenotyping polyclonal kappa and lambda light chain molecular mass distributions in patient serum using mass spectrometryDavid R Barnidge, Surendra Dasari, Marina Ramirez-Alvarado, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 10, 2011
Clinical features of patients with immunoglobulin light chain amyloidosis (AL) with vascular-limited deposition in the kidneyAlfonso Eirin, Maria V Irazabal, Morie A Gertz, et al.
Blood Cancer Journal|April 20, 2022
Body mass index associated with monoclonal gammopathy of undetermined significance (MGUS) progression in Olmsted County, MinnesotaGeffen Kleinstern, Dirk R Larson, Cristine Allmer, et al.
Mayo Clinic Proceedings|August 14, 2012
Incidence of monoclonal gammopathy of undetermined significance and estimation of duration before first clinical recognitionTerry M Therneau, Robert A Kyle, L Joseph Melton, et al.
European Heart Journal|December 25, 2004
Left atrial myopathy in cardiac amyloidosis: implications of novel echocardiographic techniquesKaren M Modesto, Angela Dispenzieri, Sanderson A Cauduro, et al.
Blood|December 13, 2005
Flow cytometric detection of circulating myeloma cells before transplantation in patients with multiple myeloma: a simple risk stratification systemDavid Dingli, Grzegorz S Nowakowski, Angela Dispenzieri, et al.
JACC. Cardiovascular Imaging|February 18, 2010
Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosisImran S Syed, James F Glockner, Dali Feng, et al.
Blood|January 31, 2009
Increased risk of monoclonal gammopathy in first-degree relatives of patients with multiple myeloma or monoclonal gammopathy of undetermined significanceCeline M Vachon, Robert A Kyle, Terry M Therneau, et al.
Pageof 76

Showing results (321-330 of 759) with videos related to

Sort By:
Pageof 76
The American Journal of Cardiology|March 25, 2008
Evidence of impaired left ventricular systolic function by Doppler myocardial imaging in patients with systemic amyloidosis and no evidence of cardiac involvement by standard two-dimensional and Doppler echocardiographyDiego Bellavia, Patricia A Pellikka, Theodore P Abraham, et al.
Blood|December 8, 2011
High-dose melphalan and peripheral blood stem cell transplantation for light-chain amyloidosis with cardiac involvementSumit Madan, Shaji K Kumar, Angela Dispenzieri, et al.
Journal of Proteome Research|August 20, 2014
Phenotyping polyclonal kappa and lambda light chain molecular mass distributions in patient serum using mass spectrometryDavid R Barnidge, Surendra Dasari, Marina Ramirez-Alvarado, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 10, 2011
Clinical features of patients with immunoglobulin light chain amyloidosis (AL) with vascular-limited deposition in the kidneyAlfonso Eirin, Maria V Irazabal, Morie A Gertz, et al.
Blood Cancer Journal|April 20, 2022
Body mass index associated with monoclonal gammopathy of undetermined significance (MGUS) progression in Olmsted County, MinnesotaGeffen Kleinstern, Dirk R Larson, Cristine Allmer, et al.
Mayo Clinic Proceedings|August 14, 2012
Incidence of monoclonal gammopathy of undetermined significance and estimation of duration before first clinical recognitionTerry M Therneau, Robert A Kyle, L Joseph Melton, et al.
European Heart Journal|December 25, 2004
Left atrial myopathy in cardiac amyloidosis: implications of novel echocardiographic techniquesKaren M Modesto, Angela Dispenzieri, Sanderson A Cauduro, et al.
Blood|December 13, 2005
Flow cytometric detection of circulating myeloma cells before transplantation in patients with multiple myeloma: a simple risk stratification systemDavid Dingli, Grzegorz S Nowakowski, Angela Dispenzieri, et al.
JACC. Cardiovascular Imaging|February 18, 2010
Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosisImran S Syed, James F Glockner, Dali Feng, et al.
Blood|January 31, 2009
Increased risk of monoclonal gammopathy in first-degree relatives of patients with multiple myeloma or monoclonal gammopathy of undetermined significanceCeline M Vachon, Robert A Kyle, Terry M Therneau, et al.
Pageof 76